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Abstract 
Insulin shows postprandial transient secretion with high doses, and fasting sustained secretion with 
low doses, selectively controling multiple functions. However, how temporal patterns and doses of 
insulin selectively control gene expression remains unknown. Here, we analyzed the temporal 
patterns and doses of insulin-dependent gene expression. We performed transcriptomic analysis of 
insulin-stimulated hepatoma FAO cells and identified 13 up-regulated insulin-responsive genes 
(IRGs) and 16 down-regulated IRGs. The up-regulated IRGs responded more quickly to step and 
pulse insulin stimulations, whereas the down-regulated IRGs showed higher sensitivity to insulin 
doses. Mathematical modeling revealed that signaling from insulin to transcription of the 
down-regulated IRGs is more rapid to insulin stimulation, whereas transcription of the up-regulated 
IRGs is more rapid. Furthermore, some of the IRGs were consistently up-regulated or 
down-regulated by insulin injection in vivo. Thus, our results suggest that transient high-dose insulin 
selectively regulates the up-regulated IRGs, whereas the sustained low-dose insulin regulates the 
down-regulated IRGs.  
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1. Introduction 
1.1 Physiological roles and time scale of insulin action  
Insulin is the hormone released from β cells in the pancreas, and is the only hormone that lowers 
blood glucose. It also regulates systemic homeostasis via multiple cellular functions, including 
metabolism and gene expression (1, 2). Insulin has been reported to exhibit specific temporal 
patterns such as additional postprandial secretion, which is a transient high-dose secretion of insulin, 
and basal fasting secretion, which is sustained low-dose secretion of insulin (3, 4). Abnormalities in 
temporal patterns and doses of insulin secretion have been shown to be related to the pathogenesis of 
type 2 diabetes mellitus (4-7). Consistent with clinical observations, we have previously shown that 
additional pulse secretion and basal sustained secretion of insulin selectively regulate metabolic 
responses such as glycolysis, glycogenesis, and gluconeogenesis through the AKT-signaling pathway 
in FAO hepatoma cells (8, 9). We have also performed metabolomics and phosphoproteomics of 
acute insulin action (<60 min) and found that acute insulin action mainly involves phosphorylation 
and allosteric regulation rather than gene expression (10). However, the transcriptomics of insulin 
action, which may be particularly important for chronic insulin action (>60 min), remains to be 
investigated.  
Temporal order of transcriptional responses to external stimuli have been grouped into three types; 
early, intermediate, or late response. For example, tumor necrosis factor (TNF) induces early (< 2 
hours), intermediate (2 to 8 hours), and late (> 8 hours) gene expressions through oscillatory 
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activation of nuclear factor kappa B (NFκB) (11). As well as temporal regulation by NFκB signaling, 
alternative splicing is also reported to delay the transcriptional responses depending on the speed of 
elongation or intron removal (12). Especially, pre-mRNA of late response genes is spliced into 
mRNA much more slowly than the intermediate response genes, although the speeds of synthesis 
and degradation of pre-mRNA of those two later groups are almost equal to each other. This 
difference leads to the difference of the response speeds between the intermediate and late response 
gene groups.  
As for the time span of protein expression, microorganisms have been well studied using various 
types of data, including transcriptome, metabolome, and proteome. Zamper et al. (13) reported that, 
in yeast cultured with a normal concentration of extracellular glucose, a subset of metabolic enzymes 
show increase in their abundances (fold change > 2
3
) depending on activities of some transcription 
factors > 2 hours after glucose depletion. They also estimated the duration of the transcription 
activities to be up to ~ 6 hours after the glucose depletion.  
 
1.2 Transcriptomic responses to constant stimulations of insulin  
Transcriptomic analyses of insulin action over 3 to 48 hours with up to five time points and three 
doses in rat H4IIE hepatoma cells (14), mouse fibroblasts (15, 16), mouse osteoclast precursors (17), 
human skeletal muscle (18), and human placenta (19) have been reported. However, the mechanisms 
by which temporal patterns and doses of insulin selectively regulate gene expression have yet not 
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been studied. For example, Hectors et al. (14) evaluated dose sensitivity of the responsiveness of 
proliferation of and transcriptome in H4IIE cells treated with 3 doses of insulin (10 pM, 1nM, or 100 
nM) for 4 time points (3, 6, 24, and 48 h). However, they did not consider rapidness of the responses. 
Dupont et al. (15) analysed a mechanism of distinct responses of signalling pathways and 
transcriptome to insulin and IGF-1 whose receptors are similar to each other, by treating mouse 
fibroblasts with 50 nM of insulin or 50 nM IGF-1 at 90 min. They just measured the response 
profiles and compared the responses to the different stimulations with a single dose for a single time 
period. They did not mention the rapidness or sensitivity to insulin. Rome et al. (18) studied in vivo 
transcriptomic responses to 3-h euglycemic hyperinsulinemic clamp with a single dose of insulin in 
skeletal muscle from healthy human bodies. Although they widely discussed biological functions of 
the insulin-regulated genes, they did not discuss any importances of the rapidness or sensitivity to 
insulin.  
 
1.3 Relationships between temporal patterns of stimulation and transcriptional response  
Behar et al. (20) theoretically and computationally formulated relationships between patterns of 
stimulation and response from signalling to gene expression under some major regulation modules. 
They also experimentally validated the ligand-specific responses of NFκB activity and 
NFκB-targeted gene expressions in response to a single dose of lipopolysaccharide or tumor necrosis 
factor in two temporal patterns of time course (sustained or 45-min pulse). Their approach was 
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outstanding but specific for NFκB-targeted gene expression. Further analyses of stimulus-dependent 
transcriptomic responses remain to be elucidated. As well as the study above, because temporal 
patterns of growth factors and extracellular stimuli have been reported to be important for selective 
regulation of cellular signaling and gene expression in many cellular systems (21, 22), temporal 
patterns and doses of insulin are likely to differentially regulate gene expression, thereby controlling 
various cellular functions. It remains unknown how insulin selectively regulates global gene 
expression via specific temporal patterns such as additional pulse and basal sustained secretions.  
 
1.4 Purpose of this study  
To address this issue, Kentaro Kawata, Dr. Shinya Kuroda, and I conceived the project. K. Kawata 
analyzed the RNA sequencing (RNA-seq) data of insulin-stimulated FAO cells. K. Kawata identified 
278 genes responsive to step stimulation of insulin, which we denoted as insulin-responsive genes 
(IRGs). Based on the functional analysis using the Kyoto Encyclopedia of the Genes and Genomes 
(KEGG) database, and on the experimental and statistical analyses using various temporal patterns 
and doses of insulin stimulations, K. Kawata and I selected 13 IRGs that showed up-regulation 
(up-regulated IRGs), including the key cholesterol synthesis gene Hmgcr [encoding 
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase], and 16 IRGs that showed 
down-regulation (down-regulated IRGs), including the key gluconeogenesis genes G6pase (encoding 
glucose-6-phosphatase) and Pck1 (encoding phosphoenolpyruvate carboxykinase 1). K. Kawata, Dr. 
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Satoshi Ohno and I found that the up-regulated IRGs responded more quickly to step (increasing 
concentrations of insulin without a decrease between concentration changes) and pulse (a single 
transient increase in insulin concentration) stimulations of insulin than did the down-regulated IRGs, 
whereas the 16 down-regulated IRGs showed higher sensitivity to insulin-doses (suppressed at low 
concentrations of insulin). S. Ohno constructed a simple mathematical models of the IRG 
expressions to reveal the distinct properties of insulin signaling and transcription of the up-regulated 
and down-regulated IRGs. Furthermore, I validated that some of the IRGs were consistently 
up-regulated or down-regulated in the liver of rats by insulin injection to their portal vein. Given that 
additional postprandial secretion transiently occurs at a high dose and that basal fasting secretion 
sustainedly occurs at a low dose, our results suggested that insulin selectively exerts its postprandial 
action through the up-regulation of gene expressions and its fasting action through the 
down-regulation of gene expressions.  
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2. Materials and Methods  
2.1 Cell culture and insulin stimulation  
Rat hepatoma FAO cells were seeded at a density of 3 × 10
6
 cells per dish on 6-cm dishes (Corning) 
or 1.3 × 10
6
 cells per well on six-well plates (Iwaki) and cultured in RPMI 1640 supplemented with 
10% (v/v) fetal bovine serum at 37°C under 5% CO2 for 2 days before deprivation of serum 
(starvation). The cells were washed twice with ice-cold phosphate-buffered saline and starved in 
serum-free medium containing 0.01 nM insulin (Sigma-Aldrich) and 10 nM dexamethasone (Wako), 
which increases the expression of gluconeogenesis genes such as G6pase and Pck1 (23), for 16 hours. 
0.01 nM insulin was added before the stimulation, and 0.01 nM insulin was present throughout the 
experiments unless specified to mimic the in vivo basal secretion during fasting (Fig. 1) (4). The 
medium was changed at 4 and 2 hours before the stimulation. For step stimulation, the cells were 
stimulated by replacing the starvation medium with medium containing the specified dose of insulin 
and then cultured for the specified duration (Fig. 2, blue line). For pulse stimulation, the cells were 
stimulated by replacing the starvation medium with medium containing 10 nM insulin for 60 min, 
washed twice with medium without insulin, and stimulated again with medium containing 0.01 nM 
insulin for the remainder of the time (Fig. 2, green line). For ramp stimulation (Fig. 2, red line), the 
starved cells were cultured on a seesaw rocker in the incubator and stimulated by continuous addition 
of insulin to a maximum of 10 nM using a microsyringe pump (KD Scientific) (9).  
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2.2 RNA sequencing  
Total RNA was extracted from FAO cells stimulated by 0.01, 1, or 100 nM insulin for 0, 15, 30, 60, 
90, 120, and 240 min using RNeasy Mini Kit (Qiagen) with deoxyribonuclease I digestion to remove 
genomic and mitochondrial DNA. mRNA was enriched from total RNA using poly(A) selection, and 
the mRNA samples were validated using the 2100 Bioanalyzer (Agilent). Standard Illumina 
protocols were used to generate 101–base pair paired-end read libraries that were sequenced on the 
HiSeq 2000 platform (Illumina) (24).  
 
2.3 Identification of differentially expressed transcripts  
The sequence data of RNA-seq were analyzed using the Tuxedo suite (25). The obtained fragments 
were aligned to the reference genome annotation Rnor_5.0 reference (Ensembl, release 73), and 
junction mappings were accomplished using TopHat2 v2.0.7 (26). The FPKM values were calculated 
using Cufflinks (27), and the differentially expressed transcripts were identified using Cuffdiff (27). 
In analysis using Cuffdiff, The default value θ = 0.05 was used as an internal parameter of false 
discovery rate (FDR). K. Kawata confirmed results of DEG selection in case the internal parameter 
was changed between 0.001 and 1 (Table 1), which I found partly consistent with the result with θ = 
0.05 (Table 2).  
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2.4 Identification of the IRGs by data filtering of the differentially expressed transcripts  
The Otsu threshold (28) of expression value of 25.6 was calculated against all FPKM values, and the 
FPKM values below the threshold were substituted with zero. K. Kawata removed transcripts with 
FPKM = 0 through all the time points. The following transcripts were excluded: transcripts with 
missing points, outliers, and large expression variations. Outliers were defined as follows: if a time 
course had a series of three successive time points and the middle one had an FPKM value ≥10% of 
the maximal FPKM value within the entire time course and the others had a value of zero, then the 
transcript was excluded. In addition, if a case had a time course with a series of three successive time 
points and the middle value was zero, whereas the others had FPKM values ≥10% of the maximal 
FPKM value, then the transcript was excluded. Regarding expression variation, absolute values of 
the difference of the two slopes of the FPKM values at a specific time point and at an early or later 
time point were calculated. Considering the distribution of the calculated values, K. Kawata set a 
threshold of 2.57, which was three times larger than the mode of the distribution, and transcripts 
involving more than three time points with that threshold were excluded. The remaining 278 
differentially expressed genes corresponding to 290 differentially expressed transcripts were denoted 
as the IRGs.  
 
2.5 Mapping of the IRGs on pathways in the KEGG database  
The IRGs were mapped on pathways in the KEGG database (29). The 278 Ensembl identifiers of the 
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IRGs corresponding to 290 IRTs were related to 203 KEGG gene identifiers using Ensembl BioMart 
(release 75) (30). Mapping the IRGs to the KEGG pathways was done using the KEGG mapper tool 
(www.kegg.jp/kegg/mapper.html). Pathways with five or more IRGs were extracted (Tables 3 and 
4).  
 
2.6 Selection of the up-regulated IRGs and down-regulated IRGs  
K. Kawata selected IRTs corresponding to the IRGs mapped on the KEGG pathways that showed 
sustained increased or decreased responses at 120 and 240 min and classified them into three groups 
on the basis of their expression patterns: the up-regulated IRTs, the down-regulated IRTs, and the 
other IRTs (Figs. 3A and 4A). For the classification of the expression patterns, K. Kawata calculated 
a mean of CVs of the IRT responses to 0.01 nM insulin and set a threshold, the mean + 2σ (0.494). 
IRTs with a CV value greater than the threshold were classified as the other IRTs. Among the IRTs 
with a CV value less than or equal to the threshold, for cases in which FPKM values for 1 and 100 
nM insulin stimulation at 120 and 240 min were greater or less than those for 0.01 nM, the IRTs 
were classified into up-regulated or down-regulated IRTs. The rest of the IRTs were classified as the 
other IRTs (Fig. 4).  
 
2.7 Quantitative reverse transcription polymerase chain reaction  
qRT-PCR was performed as previously described (8). Briefly, total RNA was extracted from FAO 
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cells using RNeasy Mini Kit (Qiagen) and reverse-transcribed into complementary DNA (cDNA) 
using the High-Capacity RNA-to-cDNA Kit (Applied Biosystems) according to the manufacturer’s 
protocol. The cDNA samples were amplified using the Power SYBR Green PCR Master Mix 
(Applied Biosystems) and the 7300 Real-Time PCR system (Applied Biosystems) according to the 
manufacturer’s protocol. The primer sequences used in the qRT-PCR analysis are listed in Table 5. 
The fold changes were calculated on the basis of the ΔΔCt method (Figs. 2, 5, 6, 7, 8, and 9) using 
the expression of 36B4 as a reference gene.  
 
2.8 Definitions of parameters for the step, pulse, ramp, and dose stimulations  
I defined the parameters that characterize the response rates and amplitudes by the pulse and ramp 
stimulation of insulin and the sensitivity to insulin dose responses (Fig. 10 and Table 6). The fold 
change over the 0-min time point was used for estimating the parameters from experiments. For the 
step stimulation, Time_Constant_Step was defined as the time when the response first reached 50% 
of the peak amplitude (1/2 Peak_Step). Time_Constant_Step was calculated on the basis of linear 
interpolation. For pulse stimulation, Time_Peak_Pulse was defined as the time when the amplitude 
of the response reached the maximum (Peak_Pulse). Time_Decay_Pulse was defined as the decay 
time when the decayed response reached 50% of the Peak_Pulse. The Time_Decay_Pulse was 
calculated on the basis of linear interpolation. Ratio_240min_Pulse was defined as the ratio of the 
amplitude at 240 min by the pulse stimulation (240min_Pulse) to that by the step stimulation 
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(240min_Step). For ramp stimulation, Time_Constant_Ramp was defined as the time when the 
amplitude reached 50% of the maximal amplitude (1/2 Peak_Ramp). The Time_Constant_Ramp and 
the Time_Constant_contStep_Ramp were calculated on the basis of linear interpolation. 
Ratio_120min_Ramp was defined by the ratio 120min_Ramp/120min_Step. Ratio_180min_Ramp 
was defined as the ratio 180min_Ramp/180min_Step. Ratio_240min_Ramp was defined as the ratio 
240min_Ramp/240min_Step. For the dose responses at 120 and 240 min, four parameters, EC50, b, n, 
and Vmax, were defined on the basis of modification of the Hill function as follows:  
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where Dose, n, EC50, b, and Vmax represent the dose of insulin, the apparent Hill’s coefficient, the 
apparent half-maximal effective concentration, and the lower limit and the upper limit of the 
dose-response curve, respectively. These parameters were estimated so the y values fitted the 
experimental data using MATLAB (version R2014a, MathWorks) based on the simplex search 
method (31) to minimize the residual sum of squares (RSS) between y and the experimental data.  
 
2.9 Wilcoxon rank-sum test  
Statistical comparisons of the medians of the parameters between the up-regulated and 
down-regulated IRGs were performed using Wilcoxon rank sum test. P values were adjusted for 
multiple testing with the Benjamini-Hochberg correction (32) using MATLAB function mafdr, and 
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the adjusted P values are shown as q values. Data are shown as median with quartiles (Figs.11, 12B 
and 13C).  
 
2.10 Hierarchical clustering of IRGs using qRT-PCR data  
I performed hierarchical clustering of the responses of the up-regulated or down-regulated IRGs to 
all stimulation patterns or step stimulation (10 nM) alone (Figs. 6 or 7, respectively). The data were 
normalized in advance as follows. For the 16 sustained increased IRGs or 18 sustained decreased 
IRGs, the data were arranged as matrices of the log2 fold change of 43 or 8 time points for all the 
stimulation patterns or the step stimulation alone, respectively. The M-by-N data matrix composed of 
the N time points of the M IRGs (M < N) was normalized by scaling the variation to 1 in the row 
direction and averaged to 0 in both the row and column directions:  
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where si⋅, xij, and x’ij represent the standard deviation (SD) at the ith row of the raw matrix, the 
element of the raw matrix at the ith row and at the jth column, and the element of the normalized 
matrix at the ith row and at the jth column, respectively. I next implemented the hierarchical 
clustering using the Euclidean distance for calculation of the intracluster distances and using Ward’s 
method for calculation of the intercluster distances (Figs. 6 and 7).  
 
2.11 Principal component analysis of the up-regulated and down-regulated IRG responses 
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using various patterns of insulin stimulation  
I conducted principal component (PC) analysis using the qRT-PCR data containing fold change over 
0 min of both the up-regulated and down-regulated IRGs in response to all the patterns of insulin 
stimulation (Fig. 14). The raw data matrix (X0) containing 29 genes for 43 time points from all the 
stimulation patterns were normalized in the same way as 2.10. Considering the effect of each 
principal component to the expression patterns, the M-by-N normalized data matrix X' (M < N) was 
decomposed by singular value decomposition as follows:  
T
MMM
TT
M
j
T
jjj
TT
vuvuvuvuUDVTVX   

222111
1
,  
where the matrices T and V represent the score matrix and the loading matrix, respectively, and 
where μj represents the jth singular value, uj and vj represent the jth eigenvector in the matrices U and 
V, respectively. The two matrices U and V satisfy the following:  
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By the way, the normalized matrix X' is also expressed as follows:  
 MNNMMNNM mmmmmXmmmXX  : ,  
where X  is an M-by-N matrix with its variances in the row direction scaled to 1, and where Mm , 
Nm , and MNm  are M-by-N matrices consisting mean values of the scaled matrix X in the row, 
column, and row-and-column directions, respectively, i.e.:  
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where im  and jm  are the mean values of the scaled matrix X in the row and column directions, 
respectively, and where m  is a mean value of all the elements of the scaled matrix X. So, the raw 
data matrix X0 is decomposed as follows:  
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where “ ” means here an operation of multiplication with respect not to 2 matrices but to each 
element of 2 matrices, and where Ms  is an M-by-N matrix consisting of standard deviations of the 
raw data matrix X0 in the row direction, i.e.:  
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where is  is a standard deviation in the ith row direction in the raw data matrix X0.  
In order to capture the variance of each principal component, I illustrated the decomposed gene 
expression profiles: the mean component ( Msm  ) and the principal components 1 to 3 
  3,2,1 jMTjjj svu  (Fig. 14F).  
 
2.12 Mathematical model and parameter estimation  
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Mathematical models of insulin-dependent IRG expression in Fig. 12 were constructed as follows:  
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where I, x, and m stand for concentration of insulin, insulin signalling-dependent transcriptional 
regulator, and mRNA of the IRGs, respectively. The former equation can be regarded as signaling 
from insulin to the nucleus (insulin signaling), and the latter equations can be regarded as the 
transcription including synthesis and degradation of the IRTs. The initial values of x were calculated 
by assuming equilibrium of x, and the initial values of m were set to mean values of experimental 
qRT-PCR measurements from step, pulse, and ramp stimulations of 10 nM insulin at 0 min. Vmax2 is 
calculated by assuming equilibrium of m at 0 min. Therefore, the remaining parameters to be 
estimated are k1, KM1, k2, KM2, and Vmax1.  
The parameters of k1, KM1, k2, KM2, and Vmax1 for each IRG were estimated to reproduce the 
mRNA time course by minimizing the RSS error:  
  
2
expRSS mm  
where mexp is the normalized time course of experimental mRNA amounts by step, pulse, ramp, or 
dose stimulation of insulin. For each IRG, the data comprised 42 data points consisting of eight time 
points by step, pulse, or ramp stimulation and two time points from nine doses. Before estimation, 
the experimental step data were normalized by dividing them by their Euclidean norm, and the pulse, 
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ramp, or dose data were divided by the Euclidean norm of qRT-PCR measurements from step 
stimulation of 10 nM insulin, which were measured on the same day as the corresponding 
experiments.  
The minimization problem of RSS was numerically solved by an evolutionary programming 
method to approach the local minimum using COPASI (complex pathway simulator) (33) on 
MATLAB, followed by application of the interior point method to reach the local minimum using 
MATLAB function fmincon. The numbers of parents and generations in the meta-evolutionary 
program were 200 and 2000, respectively. Parameter estimation was performed 30 times for each 
IRG to obtain the best parameter sets with minimized RSS. The ordinary differential equations of x 
by step or pulse stimulation were solved analytically, and the others were solved using MATLAB 
function ode15s. All simulations were performed using MATLAB (version R2014a, MathWorks) on 
a Windows machine or on the super computer system of National Institute of Genetics Research 
Organization of Information and Systems.  
 
2.13 In vivo insulin injection (insulin clamp)  
All rat studies were approved by the Kyushu University Institutional Animal Care and Use 
Committee. Ten-week-old male Sprague-Dawley rats were purchased from Japan SLC Inc. After 
overnight fasting, rats were anesthetized by isoflurane. To suppress endogenous insulin secretion, 
somatostatin was administered through the jugular vein (3 μg/kg per min). Insulin was administered 
  
22 
 
through the mesenteric vein at the indicated dose, maintaining the blood glucose concentration at a 
constant amount (150 mg/dl) (Fig. 9A). Blood was sampled at the indicated time points, and blood 
insulin amounts were measured using a rat insulin enzyme-linked immunosorbent assay kit 
(Shibayagi Co. Ltd.) (Fig. 9A). At the indicated time points, the rats were killed, and the livers were 
immediately frozen with liquid nitrogen (34). The livers were harvested, and total RNA was isolated 
using RNeasy Mini Kit (Qiagen). Total RNA was reverse-transcribed into cDNA using the 
QuantiTect Reverse Transcription Kit (Qiagen) according to the manufacturer’s protocol.  
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3. Results  
3.1 Identification of the IRGs by RNA-seq  
K. Kawata identified the IRGs and characterized those that were up-regulated and down-regulated 
according to the procedures shown in Fig. 3. We performed RNA sequencing (RNA-seq) with the 
mRNA samples from insulin-stimulated rat hepatoma FAO cells (Fig. 3A). K. Kawata mapped the 
fragment sequences obtained from RNA-seq to the rat genome using TopHat (22, 23), an alignment 
software package in the Tuxedo suite (22). K. Kawata calculated values for fragments per kilobase of 
exon per million mapped fragments (FPKM) for each sample by using Cufflinks (24), a program in 
the Tuxedo suite for transcript assembly and abundance estimation, and acquired 29,165 time 
courses of the transcripts. The FPKM values of the samples stimulated by 1 or 100 nM insulin at 
each time point for each transcript were compared to those of the control (0.01 nM insulin) by using 
Cuffdiff (24). Four hundred ninety transcripts and 437 corresponding genes were identified as 
differentially expressed transcripts (DETs) and differentially expressed genes (DEGs), respectively. 
Among them, the DETs whose expression patterns had missing point(s), outlier(s), and zig-zag 
pattern(s) were filtered out (Fig. 1B), and 290 DETs and 279 corresponding DEGs were selected as 
insulin-responsive transcripts (IRTs) and IRGs, respectively (Fig. 1A; see Materials and Methods).  
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3.2 Selection of the up-regulated and down-regulated IRGs for analysis of dynamics using 
qRT-PCR  
K. Kawata conducted functional analysis of the IRGs using the Kyoto Encyclopedia of the Genes 
and Genomes (KEGG) database (29). K. Kawata searched the database for the pathway IDs of the 
203 IRGs and extracted 170 KEGG pathways in which 97 of the 203 IRGs were mapped. K. Kawata 
selected 12 KEGG pathways where five or more IRGs were mapped (Tables 3 and 4). The 12 
pathways contained 53 IRGs and 55 corresponding IRTs (Figs. 3A and 4B; Tables 3 and 4; data file 
S1, which can be downloaded from http://stke.sciencemag.org/content/9/455/ra112). Of the 12 
pathways, “Metabolic pathways” (KEGG Pathway ID: rno01100) involved 14 IRGs, which was the 
largest number (15 IRTs). “MAPK signaling pathway” (KEGG Pathway ID: rno04010) involved 12 
IRGs, which was the second largest number (12 IRTs). Both “PI3K-Akt signaling pathway” (KEGG 
Pathway ID: rno04151) and “Bile secretion” (KEGG Pathway ID: rno04976) included seven IRGs, 
which was the third largest number (seven IRTs). Thus, the pathways where the IRGs were assigned 
are consistent with the known functions of insulin signaling, indicating that at least these 53 IRGs 
were good candidates for proceeding to the next steps in identifying the best IRGs for investigating 
temporal and dose effects of insulin signaling in liver cells. The IRGs included some of the 
immediate-early genes, such as Egr1, Egr2, c-Jun, JunB, and JunD, which were removed from the 
data set by the selection process using the KEGG database. This left 290 DETs and 278 
corresponding DEGs as insulin-responsive transcripts (IRTs) and IRGs, respectively (Fig. 3A; see 
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data file S1, which can be downloaded from http://stke.sciencemag.org/content/9/455/ra112).  
 
To extract IRGs exhibiting consistent and reproducible up-regulation or down-regulation for 
subsequent analyses on rapidness and sensitivity, I performed additional filtering of the 53 IRGs. 
From the 53 IRGs, I excluded the IRGs that highly exhibited variable expression under the control 
(0.01 nM insulin) condition (Fig. 4A; see Materials and Methods) from further study. We excluded 
from further study the IRGs whose expression level of the control (0.01 nM insulin) was highly 
variable (Fig. 4A; see Materials and Methods). Because most of the other IRGs showed a sustained 
increase or decrease, we selected those whose expression at 120 and 240 min with 1 and 100 nM 
insulin stimulations were higher and lower than those of the control (0.01 nM insulin), respectively 
(Figs. 3A and 4A). We tried to confirm the expression of the selected IRGs by qRT-PCR analyses 
(Fig. 5 and Table 5). Many of them showed Pearson correlation coefficients greater than 0.7. Of the 
sustained increased IRGs, I excluded Ppp3r1 from analysis because I could not obtain primers for 
detecting isoform-specific expression. I also excluded Serpine1 because I could not detect its 
expression by qRT-PCR. Although examined under different stimulation conditions that were used 
here, I included four up-regulated IRGs (Actb, Msmol, Rassf1, and Zyx) and two down-regulated 
IRGs (G6pase and Pck1) that were reportedly regulated in insulin-stimulated H4IIE hepatoma cells 
(Table 7) (14). At the end of the filtering process, 16 sustained increased IRGs and 18 sustained 
decreased IRGs were selected, and confirmed by RNA-seq and qRT-PCR analyses. Hereafter, I used 
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qRT-PCR for the analysis of the IRGs exhibiting a sustained increase or decrease. These genes do 
not include some notable genes that are known to play critical roles in insulin action, including 
glucokinase, whose product catalyzes phosphorylation of glucose. In this study, glucokinase might 
have been filtered out in the process of RNA-seq analysis because the gene was not mapped to 
“Metabolic pathways” in the KEGG database.  
In order to investigate functions of the DETs, K. Kawata searched for specific chromosomal 
regions where DETs were expressed in response to insulin using Ensembl database and Integrative 
Genomics Viewer (IGV) tool (35). As a result, significantly expressed region was not found on the 
rat chromosomes (Fig. 15A). Also, enrichment analysis using Biological Network Gene Ontology 
(BiNGO) tool (36) showed no notable terms (Fig. 15B).  
 
3.3 Selective control of up-regulated and down-regulated IRGs by temporal patterns and doses 
of insulin  
To examine how the expression of these genes responded to different patterns and doses of insulin 
that were similar to conditions in vivo, I applied pulse stimulation with high doses of insulin to 
mimic the transient increase that occurs after a meal and ramp stimulation with low doses of insulin 
to mimic basal insulin concentrations that would accumulate during an overnight fast (Figs. 1 and 
2A). To generate a dose-response curve, I also performed step increases in insulin concentration and 
measured the response either 120 or 240 min after increasing the dose (Fig. 2A). For the pulse 
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stimulation, the cells were placed in 0.01 nM insulin and then the concentration of insulin was 
increased to 10 nM for 60 min and the medium was returned to 0.01 nM insulin. For the ramp 
stimulation, I linearly increased the amount of insulin in the medium from 0.01 to 10 nM over the 
course of 4 hours. I monitored the change in expression of the IRGs over the 4-hour time course.  
I performed an initial screen, and cluster analysis revealed three main groups for the up-regulated 
IRGs (Fig. 6, A and B, and data files S3 to S5, which can be downloaded from 
http://stke.sciencemag.org/content/9/455/ra112). Although cluster U3 (Cxcl1, Dusp5, and Ppp1r3b) 
showed the strongest response in the averaged amplitude for the IRGs with a sustained increase, I 
eliminated these from further analysis or inclusion in the model because the response of this cluster 
to the control (0.01 nM insulin) medium change was greater than twofold (Fig. 6B). The 
down-regulated IRGs also clustered into three groups (Fig. 6, C and D), and I excluded cluster D3 
(Amacr and Cflar) from the 18 IRGs with a sustained decrease because this cluster showed no 
significant response to high doses of insulin (Fig. 6D). After this initial screen, I had 13 IRGs in the 
sustained increase group and 16 IRGs in the sustained decrease group (Table 7 and Fig. 4B), 
including those from the previous study (14), and hereafter denoted as the up-regulated and 
down-regulated IRGs. The up-regulated IRGs include genes encoding proteins involved in lipid 
synthesis, such as Hmgcr, which encodes a key enzyme involved in the key cholesterol synthesis 
(Table 4) and has previously been reported to be stimulated by insulin (37). The down-regulated 
IRGs include those encoding proteins involved in gluconeogenesis, such as G6pase and Pck1 (Table 
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4), which have previously been reported to be suppressed by insulin (38, 39).  
I repeated the step, pulse, and ramp stimulations and the steps with increasing doses of insulin (Fig. 
2A) with three biologically independent experiments and examined the responses of the up-regulated 
and down-regulated IRGs (Figs. 2B and 8, Table 6, and data file S2, which can be downloaded from 
http://stke.sciencemag.org/content/9/455/ra112). To quantitatively evaluate the responses of the 
up-regulated and down-regulated IRGs, I defined the parameters that characterize time constants and 
peak amounts of the transient and the sustained responses for each up-regulated and down-regulated 
IRG (Fig. 10A and Tables 6 and 8). The time constants represent the inverse of the rate of the 
response, and the peak amounts indicate the amplitudes of the response. I assumed that the time 
constant for the pulse stimulation represented the time constant of the “pathway,” with the pathway 
defined as a first-order, linear time-invariant system (Fig. 16). I also calculated the ratio of fold 
change of the sustained response between the step and pulse stimulation conditions and between the 
step and ramp stimulation conditions (Fig. 10A). For the dose-response data, I evaluated the 
responses of the up-regulated and down-regulated IRGs at 120 and 240 min of the step stimulation 
and defined the parameters that represented the sensitivity to insulin: Hill’s coefficient, half-maximal 
effective concentration (EC50), Vmax, and b (Fig. 10B and Tables 6 and 8). To determine whether the 
up-regulated and down-regulated IRGs exhibited different responses to insulin, I compared the 
medians of the parameters for each of the stimulation conditions. Significant differences were found 
in some of the parameters between the up-regulated and down-regulated IRGs (Fig. 11, A to D).  
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Compared with the down-regulated IRGs, the up-regulated IRGs had significantly smaller time 
constants under the step stimulation (Fig. 11A). The up-regulated IRGs had significantly smaller 
time constants under the pulse stimulation (Fig. 11B, Time_Decay_Pulse) and a significantly smaller 
ratio of fold change of sustained response at 240 min between the step and pulse stimulation 
conditions (Fig. 11B, Ratio_240min_Pulse) than the down-regulated IRGs. These two parameters 
characterized how the degradation or removal of insulin affects the rate of the response. Collectively, 
these results indicated that the up-regulated IRGs responded more rapidly to step or pulse stimulation 
than did the down-regulated IRGs.  
By evaluating the sensitivity parameters, I determined that the EC50 values at 120 and 240 min for 
the down-regulated IRGs were significantly smaller than those of the up-regulated IRGs (Fig. 11D), 
indicating that down-regulated IRGs had higher sensitivity (151 and 137 pM at 120 and 240 min, 
respectively) to insulin concentration than the up-regulated IRGs (88.4 and 13.3 nM at 120 and 240 
min, respectively). Furthermore, the Hill’s coefficient was higher for the down-regulated IRGs, 
indicating that overall cooperative action by insulin signaling and transcriptional regulation in 
down-regulated IRGs is larger than that in up-regulated IRGs, and the Vmax at both 120 and 240 min 
was higher for the up-regulated IRGs (Fig. 11D).  
Thus, up-regulated IRGs responded more rapidly to the step and pulse stimulation than did 
down-regulated IRGs. Down-regulated IRGs showed higher sensitivity than up-regulated IRGs. 
These results indicated that the expressions of the up-regulated IRGs and down-regulated IRGs were 
  
30 
 
differentially affected by the temporal patterns and doses of insulin.  
To determine whether this differential responsiveness was a general property of IRTs, I applied 
step stimulation from 0.01 to 1 to 100 nM and calculated the sensitivities and time constants of the 
other IRTs (Fig. 13 and data file S6, which can be downloaded from 
http://stke.sciencemag.org/content/9/455/ra112), including the 70 that increased and the 87 that 
decreased among the 290 IRTs. This larger cohort of IRTs exhibited a similar significant difference 
between the increased and decreased IRTs; the increased IRTs had lower sensitivity at 120 and 240 
min and faster time constant in response to each of the two concentrations of insulin stimulation (Fig. 
13 and data file S6), suggesting that these differences in responsiveness may be a general property of 
IRGs.  
In addition, to confirm the consistency of the parameter differences between the up-regulated and 
down-regulated IRGs by changing the internal threshold (FDR) of Cuffdiff, K. Kawata changed the 
threshold between 0.001 and 1, repeated identification of the DEGs (Table 1). The smaller FDR 
threshold I used, the less DEGs were identified. Six (Zyx, Gadd45a, Epha2, Actg1, Srf, and Rassf1) 
out of the 13 up-regulated IRGs were consistently identified with the threshold = 0.001. Six (Pck1, 
Irs2, Ccng2, Lpin1, Nr0b2, and G6pase) out of the 16 down-regulated IRGs were consistently 
identified with the threshold = 0.001.  
As well as identification of the DEGs, I calculated the experimental parameters (Table 8) from 
qRT-PCR data (Figs. 2 and 8) by changing the threshold between 0.001 and 1. The smaller FDR 
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threshold I used, the less parameters were significantly different. Only Ratio_240min_Pulse, which 
characterizes the rapidness of the IRG response, was significantly different even under the threshold 
= 0.001. On the other hand, parameters of the sensitivity to insulin had consistently significant 
differences between the up-regulated and down-regulated IRGs under any threshold except for 0.01. 
These results suggest conclusion of this study might have generality.  
 
3.4 Mathematical modeling of up-regulated and down-regulated IRG expression  
To gain insight into what steps in signaling pathway may control selective regulation of IRG 
expression, S. Ohno constructed simple mathematical models of the up-regulated and 
down-regulated IRG expressions (Fig. 12A). The model consists of two parts: (i) signaling from 
insulin to the nucleus, which I consider to end at transcription (insulin signaling), and (ii) 
transcription, which I consider to include synthesis and degradation of the IRTs (Fig. 12A). To 
determine the parameters on which the model was most dependent, I quantified the coefficient of 
variation (CV) in the best five models among the 30 models obtained during parameter estimation 
process (see Materials and Methods). The parameter values k1, k2, and KM1 had relatively smaller 
CVs than KM2 and Vmax1 (Fig. 17). Therefore, I analyzed k1, k2, and KM1. Note that the rate constants 
k1 and k2 (Fig. 12A) are the inverse of time constants and characterize the rapidness of the pathway 
(Fig. 16). I plotted the simulated time courses of the up-regulated and down-regulated IRGs onto the 
experimental results (Figs. 2 and 8). For the first part of the model that represents insulin signaling, 
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the calculated rate constants (k1) of the down-regulated IRGs are significantly larger than those of the 
up-regulated IRGs (Fig. 12B). Therefore, the model showed that the insulin signaling part of the 
process for the down-regulated IRGs is more rapid to insulin stimulation than this part of the process 
is for the up-regulated IRGs. For the transcription part of the process, the degradation rate constants 
of transcription (k2) of the up-regulated IRGs are significantly larger than those of the 
down-regulated IRGs (Fig. 12B), indicating that transcription of the up-regulated IRGs occurs more 
rapidly than that of the down-regulated IRGs. This suggests that the more rapid time constants of the 
up-regulated IRGs in response to the step and pulse stimulation (Figs. 11, A and B, and 12B, and 
Tables 8 and 9) depend on a more rapid rate of transcription rather than a more rapid rate of insulin 
signaling. Furthermore, the rapid degradation rate for the messages is consistent with the ability to 
respond to transient signals.  
The EC50 values at 120 and 240 min of the down-regulated IRGs in both the experiment and the 
mathematical model are significantly smaller than those of the up-regulated IRGs (Figs. 11D and 
12B and Tables 8 and 9). Together, these results indicate that the insulin signaling part of signal 
transmission for the down-regulated IRGs is more rapid than that for the up-regulated IRGs, whereas 
transcription for the up-regulated IRGs is more rapid than that for the down-regulated IRGs. In 
addition, these results suggested that the difference in rate of the response to pulse stimulation 
(Time_Decay_Pulse and Ratio_240min_Pulse) between the up-regulated and down-regulated IRGs 
is derived from differences in the rate of transcription. The model could not capture the downward 
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trend of some of the up-regulated IRGs by the step and pulse insulin stimulations. This is partly 
because of the limitation of the model structure in which the downward trend cannot be reproduced 
by the step stimulation regardless of the parameters. In case an IRG is regulated by a few preceding 
gene expressions, such IRG may be expressed or suppressed in an insulin-dependent manner. 
Although addition of an insulin-dependent suppression of mRNA to the model structure may 
improve the fitting results, it will bring another difficulty in considering the number of the preceding 
gene expression processes. Further study is necessary to address this issue.  
 
3.5 In vivo expression of up-regulated IRGs and down-regulated IRGs in the rat liver  
I next examined the in vivo expression of up-regulated and down-regulated IRGs by insulin injection 
(insulin clamp) in the rat liver (Fig. 9A and data file S7, which can be downloaded from 
http://stke.sciencemag.org/content/9/455/ra112). Four of the 13 up-regulated IRGs, including Hmgcr, 
were up-regulated by insulin injection (Fig. 9B, Table 7, and data file S8, which can be downloaded 
from http://stke.sciencemag.org/content/9/455/ra112). Five of the 16 down-regulated IRGs, including 
G6pase, Pck1, and Ehhadh, were down-regulated by insulin injection (Fig. 9B, Table 7, and data file 
S8). Notably, Hmgcr, the key gene for cholesterol synthesis, was consistently up-regulated, and 
G6pase and Pck1, key genes for gluconeogenesis, were consistently down-regulated in the rat liver 
in response to insulin injection. Although the rest of the IRGs did not show statistically significant 
responses to insulin injection in vivo, other doses of insulin or examination at other time points may 
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identify insulin-dependent changes in expression.  
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4. Discussion  
We demonstrated selective control of gene expression by temporal patterns and doses of insulin (Fig. 
18). It has been reported that the additional postprandial secretion of insulin shows a transient 
temporal pattern at a high dose (approximately on the order of nano-molar with a duration of 
approximately 3 hours), and that basal fasting secretion shows a sustained temporal pattern at a low 
dose [approximately on the order of tens of pico-molar with a duration of approximately 10 hours 
(overnight fasting)] (Fig. 1) (4). In our experiments, the medians of the EC50 values of the 
up-regulated IRGs are 88.4 nM at 120 min and 13.3 nM at 240 min, whereas those of the 
down-regulated IRGs are 151 pM at 120 min and 137 pM at 240 min (Fig. 11D and Table 8), 
suggesting that the down-regulated IRGs can respond to the basal secretion but that the up-regulated 
IRGs do not. The medians of decay time by pulse stimulation (Time_Decay_Pulse) of the 
up-regulated and down-regulated IRGs, which may correspond to the apparent time constant of the 
overall pathway from stimulation to gene expression (Figs. 11B and 13, and Table 8) (40), were 178 
and 240 min, respectively. In general, when the duration of stimulation is longer than the time 
constant of a biochemical pathway, downstream molecules can efficiently respond to the stimulation; 
however, when the duration of stimulation is shorter than the time constant of a biochemical pathway, 
downstream molecules cannot efficiently respond (40). Given that the duration of additional 
secretion (approximately 3-h duration) is longer than the time constant of the up-regulated IRGs (178 
min) and shorter than that of the down-regulated IRGs (240 min), the up-regulated IRGs rather than 
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the down-regulated IRGs, are likely to efficiently respond to the additional secretion. Taken together, 
these results suggest that the up-regulated IRGs mainly respond to the additional insulin secretion 
during the postprandial period, whereas the down-regulated IRGs mainly respond to basal insulin 
secretions that occur during fasting.  
The up-regulation or down-regulation of the IRGs we selected was consistent with previous 
reports and with the known functions of the encoded products. We have previously shown that 
additional secretion-like pulse stimulation induces transient activation of S6 kinase and production of 
fructose 1,6-bisphosphate and glycogen, whereas basal secretion-like ramp stimulation with a low 
dose of insulin induces sustained suppression of G6pase and Pck1 (8, 9). The responses of the 
down-regulated IRGs G6pase and Pck1 are consistent with the previous observations (38, 39) and 
with the known functions of the encoded products in gluconeogenesis, suggesting that the rest of the 
down-regulated IRGs can similarly respond to basal secretion. Insulin also inhibits fatty acid 
catabolism (41), and we identified Ehhadh, which encodes a metabolic enzyme associated with 
β-oxidation, as a down-regulated IRG, suggesting that β-oxidation in fatty acid catabolism is 
regulated by insulin through the suppression of gene expression. Taken together, our results suggest 
a mechanism of insulin-dependent suppression of fatty acid catabolism via down-regulation of 
Ehhadh. These IRGs were consistently down-regulated in response to insulin in the liver (Fig. 9B 
and Table 7). Postprindial insulin secretion has been reported to promote cholesterol biosynthesis (42, 
43). In support of this, we identified Hmgcr, whose product, HMG-CoA reductase, is a key enzyme 
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of cholesterol biosynthesis as an up-regulated IRGs, which is also consistent with the previous report 
(37). This IRG was consistently up-regulated in response to insulin in the liver (Fig. 9B and Table 7). 
Our results also suggest a mechanism of enhancement of cholesterol synthesis in response to the 
additional secretion of insulin. Functional clustering of the up-regulated and down-regulated IRGs 
may give us insight in a well understanding of insulin action.  
In this study, we selected the IRGs that showed sustained up-regulation or down-regulation 
because most of the DEGs showed such dynamics. According to previous reports about the temporal 
order of transcriptomic dynamics (12, 35), the profiles are generally clustered into main three groups. 
So, improvement of our experimental and analytical procedures may allow us to detect the other 
types of transcripts, including early response genes and intermediate response genes, depending on 
the experimental procedures such as additional time points or doses, additional measurements such 
as chromatin immunoprecipitation sequencing (ChIP-seq). Also, we used several patterns of insulin 
stimulation in this study, and found it useful to cluster the expression dynamics of gene expression. 
Using temporally modified stimulations can be also a clew to detect and classify the genes.  
Apart from the temporal order of gene expression, phosphoproteomic responses of key signalling 
molecules in mouse liver occur within ~ 10 min (44) . Some genes such as G6pase responds rapidly 
(< 60 min) (8). Some metabolic enzymes and metabolites show slow dynamics (through 480 min) (9, 
10). Taken together with our results of the difference of the IRG expressions, if we consider all the 
IRGs selected in this study as the late response genes, the putative scenario of IRG expressions and 
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metabolic regulation in liver can be highlighted in Fig. 19. Metabolic responses may be clustered 
depending on the response speeds of corresponding metabolic enzymes and genes.  
In conclusion, we found that the temporal patterns and doses of insulin selectively control 
expression of up-regulated and down-regulated IRGs. In the future, analysis of the upstream of IRGs, 
including insulin signaling and transcription, is needed to address the mechanism of how temporal 
patterns and doses of insulin are encoded into the expression patterns of the up-regulated and 
down-regulated IRGs. Especially In particular, it is important to integrate the analyses of 
transcription, transcription factor activity (from ChIP experiments, for example), and RNA splicing 
because the speed of transcriptional responses depends on binding affinity, number, combination of 
transcription factors, and on efficiency of intron removal (12, 35). In addition, the downstream 
functions of the IRGs are necessary to fully address how temporal patterns and doses of insulin 
selectively regulate multiple biological functions. Understanding these processes will enable us to 
develop a new strategies to treat obesity and type 2 diabetes associated with aberrant insulin 
production or tissue responsiveness.  
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5. Figures and Figure Legends 
Figure 1  
 
Figure 1. Experimental design of insulin stimulation patterns based on in vivo temporal 
patterns of blood insulin.  
The additional insulin secretion is characterized by the pulse-like transient increase with a high dose 
(approximately on the order of nM with a duration of approximately 3 h), and the basal secretion is 
characterized by the ramp-like sustained increase with a low dose (approximately on the order of 
tens pM with a duration of approximately 10 h [overnight fasting]) (4). Based on in vivo temporal 
patterns of insulin, I designed the pulse stimulation and high doses of insulin and the ramp 
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stimulation and low doses, which resemble additional and basal secretion of insulin, respectively.  
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Figure 2  
 
Figure 2. Responses of the IRGs to step, pulse, and ramp stimulations and to different doses of 
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insulin.  
(A) Insulin stimulation conditions. Left: Step stimulations to 0.01 or 10 nM insulin and the pulse and 
ramp stimulations to 10 nM insulin. Insulin concentration by ramp stimulation increases linearly. 
Right: Step stimulations used to obtain the dose-response data at 120 and 240 min. (B) Responses of 
selected up-regulated and down-regulated IRGs to the different insulin stimulation conditions and 
results of simulations. The insulin stimulation conditions are listed above the graphs. Dots are 
experimental data of means ± SD from three independent experiments, and solid lines are simulation 
data of the mathematical models (Fig. 12). Dark blue, green, and red circles and lines correspond to 
the responses to the step, pulse, and ramp stimulations of 10 nM insulin, respectively. Light blue 
circles and lines correspond to the responses to step stimulation of 0.01 nM insulin. Cyan and 
magenta circles and lines correspond to the dose response at 120 and 240 min, respectively. All 
measurements and simulations are normalized by the mean values at 0 min. Responses of all the 
up-regulated and down-regulated IRGs are shown in Fig. 8.  
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Figure 3  
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Figure 3. A pipeline for identification of the IRGs by RNA-seq.  
(A) The IRG identification procedures by RNA-seq that resulted in the selection of 13 up-regulated 
and 16 down-regulated IRGs from the 53 IRGs. Blue, green, and red solid lines describe the 
responses to step stimulation with 0.01, 1, and 100 nM insulin, respectively. (B) Data filtering of the 
differentially expressed transcripts for identification of IRTs. Differentially expressed transcripts 
with missing points, outliers, or zigzag patterns were excluded. The definition of zigzag patterns is 
shown as the last graph.  
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Figure 4  
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Figure 4. Selection of the up-regulated and down-regulated IRGs.  
(A) The 55 IRTs corresponding to the 53 IRGs were classified into sustained increased IRTs, 
sustained decreased IRTs, and the other IRTs. Blue, 0.01 nM insulin; green, 1 nM insulin; red, 100 
nM insulin. (B) Expression patterns of the sustained increased, sustained decreased, and the other 
IRTs. The names of the IRGs are substituted for those of the IRTs. The IRGs in the red and blue 
boxes indicate the up-regulated and down-regulated IRGs, respectively.  
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Figure 5  
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Figure 5. The expression amounts of the up-regulated and down-regulated IRGs measured by 
RNA-seq and qRT-PCR.  
(A) The expression patterns of the up-regulated IRGs and down-regulated IRGs were measured by 
quantitative RT-PCR (qRT-PCR) experiments. Data are shown as means ± standard deviations from 
three independent experiments. Blue, 0.01 nM insulin; green, 1 nM insulin; red, 100 nM insulin. The 
Pearson’s correlation coefficients between RNA-seq and qRT-PCR measurements are in parentheses. 
(B) Correlations of the expression amounts of the up-regulated and down-regulated IRGs between by 
RNA-seq and qRT-PCR measurements. Each dot represents the expression amounts of the 
up-regulated and down-regulated IRGs at the same time point. A Pearson’s correlation coefficient 
(R) and a regression equation are indicated.  
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Figure 6  
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Figure 6. Hierarchical clustering of expression patterns of up-regulated and down-regulated 
IRGs.  
(A) A dendrogram by hierarchical clustering of the expression patterns of the 16 sustained increased 
IRGs. Each row in the heatmap contains normalized data from each IRG in response to control media 
(0 min), the step stimulation (15, 30, 60, 90, 120, 180, and 240 min, from left to right column), the 
pulse stimulation (15, 30, 60, 90, 120, 180, and 240 min, from left to right column), the ramp 
stimulation (15, 30, 60, 90, 120, 180, and 240 min, left to right column), and the dose-responses 
(0.03, 0.1, 0.3, 1.0, 3.0, 30, and 100 nM insulin) at 120 and 240 min. Thirteen sustained increased 
IRGs in clusters U1 and U2 were selected as the up-regulated IRGs. The sustained increased IRGs in 
cluster U3 responded to the media change with the basal conditions (0.01 nM insulin) and were 
excluded from further study. The color bar represents the normalized expression amounts (see 
Materials and Methods). (B) The expression patterns of the sustained increased IRGs. Thin and thick 
lines indicate the expression pattern of each IRG in the indicated cluster and its mean, respectively. (C) 
A dendrogram by hierarchical clustering of the expression patterns of the 18 sustained decreased IRGs. 
Sixteen sustained decreased IRGs in clusters D1 and D2 were selected as the down-regulated IRGs. 
Because the responses of the sustained decreased IRGs in cluster D3 were weak, they were excluded. 
(D) The expression patterns of the sustained decreased IRGs. The heatmaps in (A) and (C) show 
normalized expression amounts, while those for time course in (B) and (D) do not because of easier 
understanding of the features. For clustering analysis, I used technical triplicates of a single 
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biological replicate as an initial screening. For the analysis of the up-regulated and down-regulated 
IRGs in Fig. 11, I used biological triplicates.  
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Figure 7  
 
Figure 7. Hierarchical clustering by the step stimulation alone.  
Hierarchical clustering using qRT-PCR data of the sustained increased or decreased IRGs in 
response to a single dose (10 nM) of the step stimulation. (A) the sustained increased IRGs labeled 
with their gene symbols and cluster names U1-U3 in parentheses (see Fig. 6A). (B) the sustained 
decreased IRGs labeled with their gene symbols and cluster names D1-D3 in parentheses (see Fig. 
6C). Color bar represents the normalized expression (see Materials and Methods).  
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Figure 8  
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Figure 8. Responses of the IRGs to step, pulse, and ramp stimulations and the dose-responses 
in experiments and in simulation.  
(A) Up-regulated IRGs. (B) Down-regulated IRGs. The first, second, third, and fourth columns 
correspond to the responses to the step, pulse, ramp, and dose-responses to insulin, respectively. Dots 
are experimental data and solid lines are simulation data of the mathematical models (Fig. 11). Dark 
blue, green, and red circles and lines correspond to the responses to the step, pulse, and ramp 
stimulation of 10 nM insulin, respectively. Light blue circles and lines correspond to the responses to 
step stimulation of 0.01 nM insulin. Cyan and magenta circles and lines correspond to the 
dose-response at 120 and 240 min, respectively. Error bars are the standard deviation of the mean (n 
= 3) values within independent experiments. All measurements and simulations are normalized by the 
mean values at 0 min. (C) Insulin stimulations. The left graph shows the step stimulations of 10 or 0.01 
nM insulin and the pulse and ramp stimulations of 10 nM insulin. Insulin concentration by ramp 
stimulation increases linearly. The right graph shows the step stimulations used to obtain 
dose-responses at 120 and 240 min.  
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Figure 9  
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Figure 9. In vivo expression of the up-regulated IRGs and down-regulated IRGs in the rat 
liver.  
(A) The concentration of blood glucose and insulin with time 0 representing the start of insulin 
injection. (B) The expression of the up-regulated and down-regulated IRGs in the liver. The 
expression of each IRG at 120 min was statistically compared with that at 0 min based on one-tailed t 
test with Benjamini-Hochberg multiple testing correction, and the adjusted P values are shown as q 
values. For these in vivo results, I considered *q < 0.05 as significant. These corrections were 
performed independently among the 13 up-regulated and the 14 down-regulated IRGs, respectively. 
Error bars are the SDs of the mean (n = 3) values within independently performed measurements. 
The two down-regulated IRGs, Nr0b2 and Xiap, were not detected and thus are not included.  
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Figure 10  
 
Figure 10. Defining the parameters for modeling up-regulated IRGs and down-regulated IRGs 
from the experimental data.  
(A) Parameters of the responses of the IRGs by the step, pulse, and ramp stimulations of insulin. I 
calculated the parameters for the down-regulated IRGs in the same way as the up-regulated IRGs 
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after converting the fold change data symmetrically with respect to the line y = 1 (0 min). (B) 
Parameters of the dose responses of the IRGs. The detailed definitions of the parameters can be 
found in Materials and Methods and Table 6.  
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Figure 11  
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Figure 11. Comparison of the parameters for the up-regulated IRGs and down-regulated 
IRGs.  
(A) Parameters for the step stimulation. (B) Parameters for the pulse stimulation. (C) Parameters for 
the ramp stimulation. (D) Parameters for the dose responses. Horizontal bold line represents the 
median, the box encompasses the 25th to 75th percentiles, and the whiskers indicate the maximum 
and minimum values. The medians of the parameters were compared between the up-regulated IRGs 
(Up) and down-regulated IRGs (Down) using Wilcoxon rank-sum test with the Benjamini-Hochberg 
multiple testing correction, and the adjusted P values are shown as q values. q < 0.01 were 
considered statistically significant (*q < 0.01). The values of the parameters for each IRG can be 
found in Table 8.  
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Figure 12  
 
Figure 12. Mathematical models of the pathway for the up-regulated IRGs and down-regulated 
IRGs.  
(A) The structure of the mathematical model. The model consists of two parts: (i) signaling from the 
insulin receptor to transcription (insulin signaling) (the upper equation) and (ii) transcription (the 
lower equations) (see Materials and Methods). Arrows indicate reactions, and lines with a circle or a 
bar indicate activation or inactivation, respectively. In the equations, I, x, and m stand for the 
concentrations of insulin, an insulin signalling-dependent transcriptional regulator, and the mRNAs 
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of the IRGs, respectively. Simulation results for all tested IRGs and stimulation conditions are shown 
as solid lines in Fig. 8. All parameters in each IRG model are shown in Table 9. (B) Box plots of the 
estimated parameters and the simulated EC50 at 120 or 240 min for the up-regulated IRGs and 
down-regulated IRGs. Horizontal bold line represents the median, the box encompasses the 25th to 
75th percentiles, and the whiskers indicate the maximum and minimum values. The medians of the 
parameters were compared between the up-regulated and down-regulated IRGs using Wilcoxon 
rank-sum test with the Benjamini-Hochberg multiple testing correction, and the adjusted P values are 
shown as q values. q < 0.01 were considered statistically significant (*q < 0.01).  
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Figure 13  
 
Figure 13. Sensitivity and time constants of the increased and decreased IRTs from the 
RNA-seq data.  
Among all the 290 IRTs (Fig. 3), I identified 70 increased and 87 decreased IRTs whose FPKM 
values at 120 and 240 min with 1 and 100 nM insulin stimulations were higher or lower than both 
those of the control (0.01 nM insulin) and those of the 0 min, respectively. (A) Sensitivity index was 
defined by the insulin-dose responses which gives the 50% activation or inhibition between 0.01 nM 
and 100 nM insulin stimulation at 120 or 240 min. (B) Time constant was defined as the time when 
the response first reached 50% of the maximum or minimum amplitude within the time series of 
FPKM values of the increased or decreased IRTs, respectively. (C) Box plots of the parameters 
between the increased and decreased IRTs. The figure code and statistical analysis were the same as 
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in Figs. 10 and 11. The effective concentrations of insulin of the decreased IRGs at 120 min and 240 
min were significantly higher than those of the increased IRGs, indicating the higher sensitivity of 
the decreased IRGs. The time constants of the increased IRGs by 1 nM and 100 nM of insulin were 
significantly faster than those of the decreased IRGs, indicating the faster response of the increased 
IRGs. Wilcoxon rank sum test with the Benjamini-Hochberg multiple testing correction, and the 
adjusted P values are shown as q values. The q values < 0.01 were considered statistically significant 
(*q value < 0.01). Gene names and the time course data of the increased and decreased IRGs can be 
seen in Supplementary Materials (data file S8, which can be downloaded from 
http://stke.sciencemag.org/content/9/455/ra112).  
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Figure 14  
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Figure 14. Analysis of response characteristics of the up-regulated and down-regulated IRGs 
by principal component analysis using various patterns of insulin stimulation.  
(A) Percentage of explained variances. Contributions of each principal component are shown as bar 
plots. The cumulative contribution is shown as a line chart. Up to 3 principal components, 
cumulative contribution of the explained variances excessed more than 80%. (B) Heat map of the 
score matrix of the up-regulated and down-regulated IRGs. Up to 8 principal components are shown. 
Color bar represents strength of the score. Gene names are listed in the vertical direction on left side. 
The 13 upper and 16 lower genes are the up-regulated and down-regulated genes, respectively. (C) 
Heat map of a loading matrix of all the stimulation patterns. Up to eight principal components are 
shown. Color bar represents strength of the loading. Gene names are listed in the vertical direction on 
left side. (D) Scatter plots of the score of the PC 1 to 3. Red and blue dots represent each of the 
up-regulated and down-regulated IRG, respectively. Up-regulated and down-regulated IRGs were 
separated in the PC1 direction. So far, we can not explain what the PC 2 and 3 score distinguish. (E) 
Scatter plots of the loading of the PC 1 to 3. A black dot, gray circles, blue circles, green squares, red 
triangles, cyan inverted triangles, and magenta inverted triangles represent 0-min response, step 
stimulation (0.01 nM), step stimulation (10 nM), pulse stimulation (10 nM), ramp stimulation (10 
nM), dose response (120 min), and dose response (240 min), respectively. The larger size of the 
markers, the later time points (0 to 240 min). In the PC1 direction, the larger amplitude of the 
response, the larger PC1 loading. In the PC2 direction, step stimulation including dose responses 
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were separated from pulse and ramp stimulations. In the PC3 direction, ramp, step, and pulse 
stimulations were separated. (F) Decomposed expression profiles using singular value 
decomposition up to the 3 principal components (see Materials and Methods). Red and blue line 
charts represent each of the up-regulated and down-regulated IRGs, respectively. PC1-decomposed 
expression might capture the variance at later time points for the step and ramp stimulation, at 120 
min for the pulse stimulation, at high doses for the dose responses. PC2-decomposed expression 
might capture the variance at 15, 30, or >180 min for the step stimulation, at 60 min for the pulse 
stimulation, at 15-30 min for the ramp stimulation. PC3-decomposed expression might capture the 
variance at 60 or 90 min for the step stimulation, at 60-90 min for the pulse stimulation, at >120 min 
for the ramp stimulation.  
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Figure 15  
A  
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B  
 
Figure 15. Chromosome mapping and gene ontology of DEGs.  
(A) A chromosome map of the DEGs on the rat genome using Integrative Genomics Viewer (IGV) 
tool (35). Horizontal and vertical axes represent length of base pairs and number of the genes per 
Mbp length, respectively. Upper panels: blue, green, or red bar represents number of the transcripts 
registered in Ensembl database, number of the transcripts detected through Otsu method, or number 
of the transcripts detected as differentially expressed by Cuffdiff (FDR threshold = 0.05), 
respectively. Lower panels: blue or green bar represents the ratio of the transcripts detected as 
differentially expressed by Cuffdiff over the transcripts registered in Ensembl database or the 
transcripts detected through Otsu method, respectively. (B) Gene ontology analysis of the DEGs 
using the BiNGO tool (Cytoscape plugin BiNGO 2.44) (36). Size of a circle represents the number of 
the statistically over-represented genes. Color bar represents the P value from the hypergeometric 
test for over-representation with multiple testing correction using Bonferroni method (FWER) or 
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Benjamini-Hochberg method (FDR). I considered the corrected P value < 0.05 as statistically 
significant. I used GOSlim_GOA as the gene ontology.  
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Figure 16  
 
Figure 16. Decay time constant by pulse stimulation represents the time constant of a pathway.  
Stimulations (u) and responses (x) of a signaling pathway approximated by first-order linear 
time-invariant system. (A) Step stimulation; (B) response to step stimulation; (C) pulse stimulation; 
(D) response to pulse stimulation. Functions of u and x are also shown.  
 
Let a signaling pathway be approximated by the following first-order linear time-invariant system:  
 
   ,tkxtu
dt
tdx
  (1) 
where x(t) is an activity of a signaling molecule, u(t) is an input by stimulation. k stands for the 
reaction constant, which is an inverse of the time constant. As for a step stimulation (Fig. 16A), u(t) 
can be described as equation (2):  
 
 




.0if
,0if0
tutu
ttu
 (2) 
When x(0) equals zero, equation (1) for the step stimulation can be solved analytically as follows:  
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   ,1 kte
k
u
tx   (3) 
where x converges u/k (Peak_Step), as t approaches infinity (Fig. 16B). When I define 
Time_Constant_Step as the time when x(t) equals the half of Peak_Step, the time constant can be 
described in equation (4):  
.2ln
1
ant_StepTime_Const
k
  (4) 
 
In a case for a pulse stimulation (Fig. 16C), u(t) can be described as equation (5):  
 
 

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 (5) 
When x(0) equals zero, equation (1) for the pulse stimulation can be solved analytically as follows:  
   
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 (6) 
where maximum x value is (u/k)(1-exp(-kt1)) (Peak_Pulse), when t equals t1 (Fig. 16D). When I 
define Time_Decay_Pulse as the time when x(t) equals the half of Peak_Pulse after t1, the time can 
be described in equation (7):  
.2ln
1
_PulseTime_Decay 1t
k
  (7) 
 
Using equations (4) and (7), Time_Constant_Step can be represented by Time_Decay_Pulse as Eq. 
(8):  
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._PulseTime_Decayant_StepTime_Const 1t  (8) 
Therefore, decay time constant, a linear function of the inverse of k, represents rapidness of the 
signaling pathway by both step and pulse stimulations. Although actual signaling pathways are much 
more complex so that strict analytical solutions are hard to be obtained, decay time constant can be 
regarded as an apparent time constant of the signaling pathway.  
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Figure 17  
 
Figure 17. Histograms of coefficient of variation (CV) of parameter values in the best 5 models 
among the 30 models.  
The coefficient of variation is quantified for each IRG in the best five models among the 30 models 
obtained during parameter estimation process.  
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Figure 18  
 
Figure 18. Selective control of the up-regulated IRGs and down-regulated IRGs by temporal 
patterns and doses of insulin.  
Mathematical modeling revealed that insulin signaling of the down-regulated IRGs is more rapid 
than that of the up-regulated IRGs, whereas transcription of the up-regulated IRGs is more rapid than 
that of the down-regulated IRGs. In experiments, the up-regulated IRGs responded more rapidly to 
step and pulse insulin stimulation, whereas the down-regulated IRGs showed higher sensitivity than 
did the up-regulated IRGs to insulin doses.  
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Figure 19  
 
Figure 19. Putative scenario of insulin action in liver.  
Previous studies (8-10, 12, 44) and our results suggest that the up-regulated and down-regulated 
IRGs respond to insulin stimulations at different speeds from each other. The up-regulated IRGs may 
be mainly regulated by slower signaling and RNA splicing, whereas the down-regulated IRGs by fast 
signalling and mRNA degradation. In this study, we considered only the late response genes (“Late 
transcription”) as the IRGs. Improvement of experimental and analytical procedures may allow us to 
comprehensively discuss all the groups of the gene expressions.  
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6. Tables  
Table 1. Validation of Cuffdiff to identify the DEGs by changing the Cuffdiff’s internal 
threshold (FDR).  
 Gene 
symbol 
FDR 
(sorted) 
FDR threshold 
0.001 0.005 0.01 0.05 0.1 0.5 0.9 1 
U
p
-r
e
g
u
la
te
d
 I
R
G
s 
Zyx 0.0×100 DEG DEG DEG DEG DEG DEG DEG DEG 
Gadd45a 1.3×10-12 DEG DEG DEG DEG DEG DEG DEG DEG 
Epha2 1.0×10-10 DEG DEG DEG DEG DEG DEG DEG DEG 
Actg1 6.6×10-6 DEG DEG DEG DEG DEG DEG DEG DEG 
Srf 1.3×10-4 DEG DEG DEG DEG DEG DEG DEG DEG 
Rassf1 2.7×10-4 DEG DEG DEG DEG DEG DEG DEG DEG 
Ajuba 0.006   DEG DEG DEG DEG DEG DEG 
Mat2a 0.006   DEG DEG DEG DEG DEG DEG 
Msmo1 0.007   DEG DEG DEG DEG DEG DEG 
Actb 0.015    DEG DEG DEG DEG DEG 
Hbegf 0.025    DEG DEG DEG DEG DEG 
Gabbr1 0.031    DEG DEG DEG DEG DEG 
Hmgcr 0.046    DEG DEG DEG DEG DEG 
D
o
w
n
-r
e
g
u
la
te
d
 I
R
G
s 
Pck1 1.2×10-12 DEG DEG DEG DEG DEG DEG DEG DEG 
Irs2 2.7×10-9 DEG DEG DEG DEG DEG DEG DEG DEG 
Ccng2 3.6×10-9 DEG DEG DEG DEG DEG DEG DEG DEG 
Lpin1 2.1×10-6 DEG DEG DEG DEG DEG DEG DEG DEG 
Nr0b2 3.0×10-6 DEG DEG DEG DEG DEG DEG DEG DEG 
G6pase 8.3×10-5 DEG DEG DEG DEG DEG DEG DEG DEG 
Cyp2b1 0.002  DEG DEG DEG DEG DEG DEG DEG 
Ehhadh 0.007   DEG DEG DEG DEG DEG DEG 
Abcg8 0.009   DEG DEG DEG DEG DEG DEG 
Creb3l3 0.012    DEG DEG DEG DEG DEG 
B3galt1 0.018    DEG DEG DEG DEG DEG 
Ppap2b 0.022    DEG DEG DEG DEG DEG 
Gadd45b 0.022    DEG DEG DEG DEG DEG 
Upp2 0.026    DEG DEG DEG DEG DEG 
Xiap 0.033    DEG DEG DEG DEG DEG 
Creb3l2 0.047    DEG DEG DEG DEG DEG 
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Table 2. q values from experimental parameter comparisons between the up-regulated and 
down-regulated IRGs by changing the Cuffdiff’s internal threshold (FDR).  
Parameter 
FDR threshold 
0.001 0.005 0.01 0.05 0.1 0.5 0.9 1 
Time_Constant_Step 0.15 0.082 0.08 6.3×10-3* 6.3×10-3* 6.3×10-3* 6.3×10-3* 6.3×10-3* 
Time_Peak_Pulse 0.21 0.093 0.028 0.071 0.071 0.071 0.071 0.071 
Time_Decay_Pulse 0.035 0.021 1.6×10-3* 1.1×10-3* 1.1×10-3* 1.1×10-3* 1.1×10-3* 1.1×10-3* 
Ratio_240min_Pulse 6.9×10-3* 3.7×10-3* 4.4×10-4* 2.5×10-3* 2.5×10-3* 2.5×10-3* 2.5×10-3* 2.5×10-3* 
Time_Constant_Ramp 0.32 0.24 0.091 0.013 0.013 0.013 0.013 0.013 
Ratio_120min_Ramp 0.15 0.082 0.15 0.015 0.015 0.015 0.015 0.015 
Ratio_180min_Ramp 0.45 0.42 0.99 0.98 0.98 0.98 0.98 0.98 
Ratio_240min_Ramp 0.45 0.42 0.76 0.86 0.86 0.86 0.86 0.86 
Hill’s coefficient(120 min) 0.012 6.2×10-3* 7.3×10-3* 1.7×10-3* 1.7×10-3* 1.7×10-3* 1.7×10-3* 1.7×10-3* 
Hill’s coefficient(240 min) 0.82 0.95 0.27 0.21 0.21 0.21 0.21 0.21 
EC50 (120 min) 6.9×10-3* 3.7×10-3* 0.043 4.6×10-3* 4.6×10-3* 4.6×10-3* 4.6×10-3* 4.6×10-3* 
EC50 (240 min) 6.9×10-3* 3.7×10-3* 4.4×10-4* 9.1×10-5* 9.1×10-5* 9.1×10-5* 9.1×10-5* 9.1×10-5* 
Vmax (120 min) 6.9×10-3* 3.7×10-3* 2.5×10-3* 2.5×10-3* 2.5×10-3* 2.5×10-3* 2.5×10-3* 2.5×10-3* 
Vmax (240 min) 6.9×10-3* 3.7×10-3* 4.4×10-4* 1.7×10-3* 1.7×10-3* 1.7×10-3* 1.7×10-3* 1.7×10-3* 
b (120 min) 0.082 0.044 0.038 2.5×10-3* 2.5×10-3* 2.5×10-3* 2.5×10-3* 2.5×10-3* 
b (240 min) 0.63 0.89 1.0×100 0.81 0.81 0.81 0.81 0.81 
*q value < 0.01 after multiple testing correction based on Benjamini-Hochberg method (see 
Materials and Methods).  
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Table 3. KEGG pathways into which five or more IRGs mapped.  
KEGG pathway name  KEGG pathway ID  
Numbers of  
mapped IRGs  
Metabolic pathways  rno01100  14  
MAPK signaling pathway  rno04010  12  
Bile secretion  rno04976  7  
PI3K-Akt signaling pathway  rno04151  7  
Estrogen signaling pathway  rno04915  6  
Insulin signaling pathway  rno04910  6  
Hippo signaling pathway  rno04390  6  
p53 signaling pathway  rno04115  6  
Focal adhesion  rno04510  6  
TNF signaling pathway  rno04668  5  
Cell cycle  rno04110  5  
Ras signaling pathway  rno04014  5  
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Table 4. KEGG pathways in which the up-regulated and down-regulated IRGs were mapped.  
Up-regulated IRGs  KEGG pathway(s)  
Actb  Focal adhesion, Hippo signaling pathway  
Actg1  Focal adhesion, Hippo signaling pathway  
Ajuba  Hippo signaling pathway  
Epha2  PI3K-Akt signaling pathway, Ras signaling pathway  
Gabbr1  Estrogen signaling pathway  
Gadd45a  Cell cycle, MAPK signaling pathway, p53 signaling pathway  
Hbegf  Estrogen signaling pathway  
Hmgcr  Metabolic pathways, bile secretion  
Mat2a  Metabolic pathways  
Msmo1  Metabolic pathways  
Rassf1  Hippo signaling pathway, Ras signaling pathway  
Srf  MAPK signaling pathway  
Zyx  Focal adhesion  
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Down-regulated IRGs  KEGG pathway(s)  
Abcg8  Bile secretion  
B3galt1  Metabolic pathways  
Ccng2  p53 signaling pathway  
Creb3l2  
Estrogen signaling pathway, PI3K-Akt signaling pathway, 
TNF signaling pathway  
Creb3l3  
Estrogen signaling pathway, PI3K-Akt signaling pathway, 
TNF signaling pathway  
Cyp2b1  Metabolic pathways  
Ehhadh  Metabolic pathways  
G6pase  
Insulin signaling pathway, metabolic pathways, PI3K-Akt 
signaling pathway  
Gadd45b  Cell cycle, MAPK signaling pathway, p53 signaling pathway  
Irs2  Insulin signaling pathway  
Lpin1  Metabolic pathways  
Nr0b2  Bile secretion  
Pck1  
Insulin signaling pathway, metabolic pathways, PI3K-Akt 
signaling pathway  
Ppap2b  Metabolic pathways  
Upp2  Metabolic pathways  
Xiap  Focal adhesion  
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Table 5. Primer sequences used for qRT-PCR measurements.  
Sustained 
increased  
IRGs  
Forward  Reverse  
Actb† ACCAGTTCGCCATGGATGAC  TGCCGGAGCCGTTGTC  
Actg1† GAGTCAGGCCCCTCCATTGT  GCCTGGCACCTGCTCAGT  
Ajuba† TGAGAGGGCATCACAGAAACC  GGCCAAGCTAACCCTATGTGAA  
Cxcl1 CAGACAGTGGCAGGGATTCA  CCTGGCGGCATCACCTT  
Dusp5 CAGGGTGGCCCAGTTGAA  GATGCATGGTAGGCACTTCCA  
Epha2† GCATTGCTCTCTGTTCGTGTCT  GGAAGCGGGCCAAGCT  
Gabbr1† TCTCCATTCTGCCCCAGTTG  CATAGAAAATGCCAAGCCACGTA  
Gadd45a† TGGCTGCGGATGAAGATGA  CACGAATGAGGGTGAAATGGA  
Hbegf† TCTTTCTGGCCGCAGTGTT  GAAGCCGCTCCAGACTCTCA  
Hmgcr† CTGGGCCCCACGTTCA  ATGGTGCCAACTCCAATCACA  
Mat2a† CTTGGTTACGCCCAGATTCTAAA  CACAGCACCTCGATCTTGCA  
Msmo1† TCACGATTTCCACCACATGAA  TGTCCCACCACGTGAAGGT  
Ppp1r3b GGACAGCAACAAAGGCAAAAAC  TTCCCTGGGTGGATCTGAGTT  
Ppp3r1 CGGACTTGCAGTCACAGATTTTC  GAAGTGGTCTTTGCCTTTTTTCC  
Rassf1† CTGGAGCAGCACGACAAGTAGT  TGAAGTACTGCTCGAGCTCTGAGT  
Serpine1 TCCGGATGGGCACGAGTA  GAGGGTTTCGCCGTGGTA  
Srf† CACGACCTTCAGCAAGAGGAA  CAGCGTGGACAGCTCATAAGC  
Zyx† TGTCCTCACTGCTGGATGACA  TGACACCCGGGCTTTGA  
†
Up-regulated IRGs.  
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Sustained 
decreased  
IRGs  
Forward  Reverse  
Abcg8‡ CACCTACAGTGGTCAGTCCAACAC  CTCAAACCAAGGCACCTGAGA  
Amacr GGTCATTGATGCGAACATGGTGGAA  CCCATGGCTTGAGTTTTCCA  
B3galt1‡ AATGGCGGGCCAATCAG  CAGGGTACAAATCCCTAGGCATA  
Ccng2‡ TCAGGAATGCACCTTCTTCTTTG  TGAACTCTAAGGTGGAAAGCACAGT  
Cflar GGGTGCGGCGGTTTG  CCACCGCTGCTTTATCTGTCT  
Creb3l2‡ TGGTCGTTGTGCTTTGCTTT  GATACAGCCCGTAGCCTTGAAA  
Creb3l3‡ TGGATCCGCTAACGTTGCA  GCCCCTCGCCTTGCTT  
Cyp2b1‡ CCCCCATGTCGCAGAGAA  CCGGTGTGAGCCGATCAC  
Ehhadh‡ TCCGGGCAGGCTAAAGC  TGACCACTTATTTGCAGACTTTTCA  
G6pase‡ CAGCCCGTGTAATGAGTAGC  GATGAGTCCTATGGCACGCAGACCT  
Gadd45b‡ TGCTGGCCATAGACGAAGAA  ATCAGGGTGAAGTGAATTTGCA  
Irs2‡ CAAGAACCTGACCGGTGTATACC  GGCTGTTCGCAATTGAGCTT  
Lpin1‡ CCGTGTCATATCAGCAATTTGC  GACCACGAGGTTGGGATCAT  
Nr0b2‡ CGCCTGGCCCGAATC  GAAGGGTACAGGAGATGTTCTTGAG  
Pck1‡ CGCTATGCGGCCCTTCT  AGCCAGTGCGCCAGGTACT  
Ppap2b‡ TTTTCGGCTGTGCCATCA  GCGCCCAATGGACACTTT  
Upp2‡ TGGTGGGAGCTCGAACAGA  AACCCGAGTTCCTTGTGCAT  
Xiap‡ GCCCGCGGCGGTTA  AATACGACTTGTCCACCTTTTCG  
‡
Down-regulated IRGs.  
 
  
85 
 
Table 6. Parameters of the experimental IRG responses.  
Stimulation  Parameter  Description  
Step  
(Fig. 10A)  
Time_Constant_Step  
Time when the expression 
amount reached 1/2 Peak_Step  
Pulse  
(Fig. 10A)  
Time_Peak_Pulse  
Time when the expression 
amount reached Peak_Pulse  
Time_Decay_Pulse  
Time when the expression 
amount reached 1/2 Peak_Pulse  
after the time of Peak_Pulse  
Ratio_240min_Pulse  240min_Pulse / 240min_Step  
Ramp  
(Fig. 10A)  
Time_Constant_Ramp  
Time when the expression 
amount reached 1/2 Peak_Ramp  
Ratio_120min_Ramp  120min_Ramp / 120min_Step  
Ratio_180min_Ramp  180min_Ramp / 180min_Step  
Ratio_240min_Ramp  240min_Ramp / 240min_Step  
Dose-response  
(Fig. 10B) 
Hill’s coefficient,  
EC50 , Vmax , and b  
Each parameter was estimated  
at 120 and 240 min  
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Table 7. Up-regulated IRGs and down-regulated IRGs.  
Up-regulated IRGs  Down-regulated IRGs  
Actb*  Abcg8  
Actg1  B3galt1  
Ajuba  Ccng2†  
Epha2  Creb3l2  
Gabbr1  Creb3l3  
Gadd45a†  Cyp2b1  
Hbegf  Ehhadh†  
Hmgcr†  G6pase*†  
Mat2a  Gadd45b  
Msmo1*  Irs2†  
Rassf1*  Lpin1  
Srf†  Nr0b2  
Zyx*†  Pck1*†  
 Ppap2b  
 Upp2  
 Xiap  
*Up-regulated and down-regulated genes by insulin stimulation (100 nM for 6 hours) in rat H4IIE 
hepatoma cells (11). Note that the cell line and the time point are different from those of our study.  
†Up-regulated and down-regulated IRGs by insulin injection in the liver (Fig. 9).  
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Table 8. Calculated parameters from experimental qRT-PCR data.  
Up-regulated 
IRGs 
Time_ 
Constant_ 
Step 
(min) 
Time_ 
Peak_ 
Pulse 
(min) 
Time_ 
Decay_ 
Pulse 
(min) 
Ratio_ 
240min_ 
Pulse 
Time_ 
Constant_ 
Ramp 
(min) 
Actb 6.27×101 2.40×102 2.40×102 3.80×10-1 6.78×101 
Actg1 5.87×101 1.20×102 2.40×102 2.04×10-1 6.58×101 
Ajuba 7.02×101 1.20×102 2.02×102 1.25×10-1 6.54×101 
Epha2 4.06×101 6.00×101 1.42×102 3.06×10-3 5.77×101 
Gabbr1 1.07×101 3.00×101 7.06×101 6.78×10-1 4.11×101 
Gadd45a 2.72×101 9.00×101 1.67×102 4.09×10-1 1.83×101 
Hbegf 2.38×101 6.00×101 1.03×102 4.20×10-2 4.56×101 
Hmgcr 3.54×101 1.20×102 1.78×102 6.67×10-1 5.97×101 
Mat2a 4.75×101 1.20×102 2.24×102 2.83×10-1 4.87×101 
Msmo1 7.07×101 1.20×102 1.88×102 0.00×100 8.87×101 
Rassf1 3.91×101 6.00×101 1.43×102 2.15×10-1 1.24×102 
Srf 4.13×101 1.20×102 1.76×102 2.89×10-2 5.40×101 
Zyx 5.55×102 1.20×102 2.25×102 2.84×10-1 6.56×101 
 
Up-regulated 
IRGs 
Ratio_ 
120min_ 
Ramp 
Ratio_ 
180min_ 
Ramp 
Ratio_ 
240min_ 
Ramp 
Hill’s 
coefficient 
(120 min) 
Hill’s 
coefficient 
(240 min) 
Actb 7.99×10-1 8.47×10-1 1.07×100 3.96×10-1 7.88×10-1 
Actg1 1.09×100 1.00×100 9.59×10-1 2.76×10-1 7.31×10-1 
Ajuba 1.27×100 1.25×100 1.53×100 8.66×10-1 6.60×10-1 
Epha2 1.28×100 1.60×100 1.24×100 2.90×10-1 1.05×100 
Gabbr1 0.00×100 1.12×100 1.59×10-1 1.00×10-1 1.00×101 
Gadd45a 3.21×10-1 5.67×10-1 6.27×10-1 2.64×10-1 1.00×101 
Hbegf 8.63×10-1 1.23×100 1.03×100 2.74×10-1 6.34×10-1 
Hmgcr 6.55×10-1 1.08×100 1.74×100 1.42×10-1 3.05×10-1 
Mat2a 1.29×100 1.20×100 1.37×100 9.34×10-1 4.53×10-1 
Msmo1 1.21×100 1.16×100 1.44×100 1.36×10-1 4.23×10-1 
Rassf1 9.25×10-1 1.20×100 1.40×100 2.40×10-1 3.59×100 
Srf 6.42×10-1 8.11×10-1 7.56×10-1 2.84×10-1 6.44×10-1 
Zyx 7.60×10-1 6.45×10-1 5.94×10-1 5.93×10-1 1.31×100 
 
  
88 
 
 
Up-regulated 
IRGs 
EC50 (nM) 
(120 min) 
EC50 (nM) 
(240 min) 
Vmax 
(120 min) 
Vmax 
(240 min) 
b 
(120 min) 
b 
(240 min) 
Actb 8.68×10-1 1.30×101 1.30×100 1.69×100 9.89×10-1 1.28×100 
Actg1 8.84×101 8.27×100 4.36×100 3.44×100 5.79×10-1 8.52×10-1 
Ajuba 2.42×10-1 1.28×101 1.22×100 2.16×100 9.39×10-1 1.11×100 
Epha2 1.00×106 1.56×101 7.28×101 3.73×100 9.56×10-1 1.46×100 
Gabbr1 2.71×100 1.33×101 2.52×100 6.24×10-1 7.46×10-10 1.02×100 
Gadd45a 1.00×106 1.17×101 3.31×101 1.98×100 7.27×10-1 1.24×100 
Hbegf 1.00×106 3.69×101 3.98×101 3.32×100 7.77×10-1 1.06×100 
Hmgcr 1.00×106 1.00×106 5.77×100 1.50×101 7.99×10-1 1.04×100 
Mat2a 1.10×10-1 1.75×100 9.27×10-1 1.66×100 8.36×10-1 7.66×10-1 
Msmo1 7.26×10-3 7.30×101 1.77×100 1.24×100 1.04×10-9 9.05×10-1 
Rassf1 1.00×106 1.50×101 2.14×101 1.50×100 7.22×10-1 1.21×100 
Srf 2.97×102 2.83×101 6.55×100 3.20×100 5.52×10-1 8.70×10-1 
Zyx 1.63×101 1.32×101 7.89×100 5.72×100 6.74×10-1 7.83×10-1 
 
Down-regulated 
IRGs 
Time_ 
Constant_ 
Step 
(min) 
Time_ 
Peak_ 
Pulse 
(min) 
Time_ 
Decay_ 
Pulse 
(min) 
Ratio_ 
240min_ 
Pulse 
Time_ 
Constant_ 
Ramp 
(min) 
Abcg8 1.07×102 2.40×102 2.40×102 9.38×10-1 1.42×102 
B3galt1 5.78×101 1.20×102 1.73×102 0.00×100 7.23×101 
Ccng2 3.55×101 1.20×102 2.40×102 6.04×10-1 6.09×101 
Creb3l2 1.09×102 1.80×102 2.40×102 8.72×10-1 9.28×101 
Creb3l3 1.17×102 2.40×102 2.40×102 9.06×10-1 7.43×101 
Cyp2b1 1.29×102 1.80×102 2.40×102 5.85×10-1 9.74×101 
Ehhadh 5.95×101 1.80×102 2.40×102 4.07×10-1 1.12×102 
G6pase 5.37×101 1.20×102 2.37×102 4.28×10-1 5.81×101 
Gadd45b 2.60×101 6.00×101 2.40×102 6.70×10-1 7.19×101 
Irs2 6.07×101 9.00×101 2.40×102 5.47×10-1 8.17×101 
Lpin1 6.82×101 1.20×102 2.40×102 5.05×10-1 8.22×101 
Nr0b2 8.77×101 1.80×102 2.40×102 7.10×10-1 7.64×101 
Pck1 9.24×101 1.80×102 2.40×102 8.27×10-1 9.79×101 
Ppap2b 9.17×101 9.00×101 2.40×102 5.38×10-1 1.66×102 
Upp2 8.54×101 1.80×102 2.40×102 7.60×10-1 8.98×101 
Xiap 1.10×102 9.00×101 2.40×102 8.42×10-1 1.27×101 
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Down-regulated 
IRGs 
Ratio_ 
120min_ 
Ramp 
Ratio_ 
180min_ 
Ramp 
Ratio_ 
240min_ 
Ramp 
Hill’s 
coefficient 
(120 min) 
Hill’s 
coefficient 
(240 min) 
Abcg8 1.53×100 1.35×100 1.15×100 1.00×101 3.54×100 
B3galt1 1.17×100 1.09×100 1.14×100 4.07×10-1 4.64×10-1 
Ccng2 9.13×10-1 1.00×100 9.60×10-1 3.26×10-1 1.85×100 
Creb3l2 1.23×100 9.76×10-1 9.21×10-1 1.00×101 3.62×10-1 
Creb3l3 1.20×100 1.17×100 1.09×100 3.92×10-1 1.89×100 
Cyp2b1 1.40×100 1.14×100 1.14×100 1.03×100 9.89×10-1 
Ehhadh 1.15×100 1.12×100 9.55×10-1 1.62×100 1.10×100 
G6pase 1.04×100 1.01×100 1.01×100 7.32×10-1 1.76×100 
Gadd45b 4.09×101 1.21×101 3.82×100 3.78×10-1 1.00×101 
Irs2 1.38×100 1.20×100 1.17×100 8.89×10-1 2.58×100 
Lpin1 1.40×100 1.07×100 1.05×100 1.15×100 6.40×10-1 
Nr0b2 1.12×100 1.05×100 1.01×100 7.58×10-1 1.66×100 
Pck1 1.23×100 1.06×100 1.02×100 2.27×100 1.96×100 
Ppap2b 8.83×10-1 9.84×10-1 1.06×100 1.00×101 1.12×100 
Upp2 1.44×100 1.13×100 1.06×100 9.87×10-1 2.19×100 
Xiap 9.05×10-1 7.83×10-1 8.14×10-1 5.06×10-1 2.06×100 
 
Down-regulated 
IRGs 
EC50 (nM) 
(120 min) 
EC50 (nM) 
(240 min) 
Vmax 
(120 min) 
Vmax 
(240 min) 
b 
(120 min) 
b 
(240 min) 
Abcg8 5.10×10-1 1.76×10-1 1.42×10-1 3.13×10-1 6.83×10-1 6.32×10-1 
B3galt1 6.05×10-1 1.47×10-1 1.72×100 1.87×100 2.12×100 2.44×100 
Ccng2 5.90×10-5 1.41×10-1 3.62×100 5.20×10-1 3.74×100 7.13×10-1 
Creb3l2 4.14×100 1.17×10-4 1.86×10-1 4.78×100 1.29×100 5.56×100 
Creb3l3 1.77×10-6 1.33×10-1 9.34×100 5.54×10-1 1.00×10-1 9.79×10-1 
Cyp2b1 6.07×10-1 1.59×10-1 3.31×10-1 8.68×10-1 1.14×100 1.26×100 
Ehhadh 1.53×10-1 9.69×10-2 4.86×10-1 1.02×100 1.35×100 1.91×100 
G6pase 7.34×10-2 1.72×10-1 1.31×100 1.27×100 1.46×100 1.42×100 
Gadd45b 3.23×10-6 1.10×10-1 9.50×100 2.05×10-1 1.00×10-1 7.23×10-1 
Irs2 1.33×10-1 1.74×10-1 4.33×10-1 4.46×10-1 8.65×10-1 8.01×10-1 
Lpin1 6.44×10-2 4.97×10-2 5.69×10-1 9.72×10-1 9.58×10-1 1.31×100 
Nr0b2 1.52×10-1 1.24×10-1 5.87×10-1 7.80×10-1 9.23×10-1 9.76×10-1 
Pck1 8.12×10-2 9.93×10-2 3.52×10-1 5.46×10-1 6.99×10-1 6.96×10-1 
Ppap2b 3.48×100 1.77×10-1 2.65×10-1 6.00×10-1 9.49×10-1 1.18×100 
Upp2 1.50×10-1 1.09×10-1 6.66×10-1 9.06×10-1 1.39×100 1.47×100 
Xiap 9.11×10-1 1.87×10-1 2.89×10-1 3.32×10-1 8.75×10-1 9.19×10-1 
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Table 9. Estimated model parameters and simulated EC50 at 120 or 240 min for the 
up-regulated and down-regulated IRGs.  
Up-regulated 
IRGs 
k1 
(1/min) 
KM1 
(nM) 
k2 
(1/min) 
KM2 
(nM) 
Vmax1 
(nM/min) 
EC50 (nM) 
(120 min) 
EC50 (nM) 
(240 min) 
Actb 3.46×10-5 4.59×100 2.25×105 2.32×10-7 1.98×10-9 1.06×100 1.97×100 
Actg1 1.95×10-5 7.96×100 1.59×105 8.08×10-6 1.83×10-8 2.30×100 5.40×100 
Ajuba 1.88×10-4 9.64×10-1 2.80×100 1.25×10-6 1.13×10-8 2.21×10-1 3.96×10-1 
Epha2 2.22×10-4 3.22×100 6.07×104 7.50×10-7 1.72×10-8 4.56×10-1 6.29×10-1 
Gabbr1 3.74×10-6 7.70×103 2.58×102 2.00×104 6.53×104 2.08×101 2.09×101 
Gadd45a 6.06×10-5 3.36×105 6.06×105 1.08×10-5 7.05×10-3 2.83×100 2.83×100 
Hbegf 1.48×10-4 7.22×100 4.15×105 4.30×10-7 2.03×10-8 6.71×10-1 8.20×10-1 
Hmgcr 2.77×10-4 4.80×100 1.01×10-1 1.64×10-7 3.45×10-8 2.18×10-1 2.41×10-1 
Mat2a 3.98×10-4 5.33×10-1 4.44×101 7.45×10-7 1.08×10-8 1.09×10-1 1.74×10-1 
Msmo1 1.20×10-4 8.41×10-1 1.28×10-1 2.03×10-7 1.64×10-9 2.05×10-1 4.12×10-1 
Rassf1 3.51×10-5 9.97×101 1.64×104 2.47×10-7 5.22×10-8 2.88×100 3.06×100 
Srf 1.74×10-5 6.15×105 8.32×105 1.02×10-6 6.40×10-4 6.48×100 6.48×100 
Zyx 3.47×10-5 1.43×104 4.50×102 1.46×10-6 1.32×10-5 7.80×100 7.81×100 
 
Down-regulated 
IRGs 
k1 
(1/min) 
KM1 
(nM) 
k2 
(1/min) 
KM2 
(nM) 
Vmax1 
(nM/min) 
EC50 (nM)  
(120 min)  
EC50 (nM)  
(240 min)  
Abcg8 4.12×10-3 1.42×10-1 7.36×10-3 7.04×10-5 1.09×10-5 9.35×10-3 1.58×10-2 
B3galt1 2.12×10-2 1.18×100 2.11×10-2 2.97×10-0 1.32×10-1 3.04×10-1 3.88×10-1 
Ccng2 1.10×10-2 4.22×10-1 6.29×10-2 2.43×10-6 1.94×10-7 5.13×10-2 5.61×10-2 
Creb3l2 3.44×10-2 2.85×102 3.00×10-3 5.77×10-7 1.47×10-4 2.17×10-2 4.39×10-2 
Creb3l3 3.32×10-2 3.90×105 4.72×10-3 5.20×10-7 2.23×10-1 1.89×10-2 3.36×10-2 
Cyp2b1 3.17×10-4 5.57×10-1 1.11×10-2 1.93×10-7 5.26×10-7 5.80×10-2 1.34×10-1 
Ehhadh 1.13×10-2 9.69×10-1 3.15×10-2 1.42×10-2 2.01×10-4 3.07×10-1 4.56×10-1 
G6pase 1.53×10-2 2.00×100 2.17×10-2 1.11×10-4 2.40×10-5 1.16×10-1 1.41×10-1 
Gadd45b 1.29×10-2 2.51×10-1 5.56×101 1.25×104 2.11×102 9.49×10-2 1.12×10-1 
Irs2 7.44×10-3 2.60×10-1 3.42×10-2 4.51×104 1.16×103 5.19×10-2 7.14×10-2 
Lpin1 9.65×10-3 3.34×10-1 2.36×10-2 1.41×10-3 5.35×10-5 5.58×10-2 7.86×10-2 
Nr0b2 5.53×10-3 3.68×10-1 1.81×10-2 6.38×102 4.09×101 3.29×10-2 4.83×10-2 
Pck1 2.26×10-3 2.84×10-1 1.40×10-2 1.24×10-5 2.64×102 1.26×10-2 1.79×10-2 
Ppap2b 2.90×10-2 7.23×100 3.40×10-3 3.17×102 1.02×102 2.72×10-1 6.62×10-1 
Upp2 3.68×10-3 3.13×10-1 2.05×10-2 3.88×102 1.21×101 4.06×10-2 6.53×10-2 
Xiap 3.57×10-2 5.31×101 3.42×10-3 3.58×10-7 1.72×10-5 2.24×10-2 4.44×10-2 
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